IN-HOSPITAL MORTALITY AMONG PATIENTS WITH ACUTE CORONARY SYNDROME WITH HIGH NEUTROPHIL TO LYMPHOCYTE RATIO

Authors

  • Sahib Khan Khyber Medical College/Khyber Teaching Hospital, Peshawar
  • Habib Ur Razaq Khyber Medical College/Khyber Teaching Hospital, Peshawar
  • Abat Khan Khyber Teaching hospital, Peshawar

Abstract

Background: High neutrophil to lymphocyte has a great impact on mortality in people with coronary artery disease. Objective of the study was to find out the frequency of in hospital mortality in acute coronary syndrome and high neutrophil to lymphocyte ratio Methods: This study was conducted in cardiology unit, Khyber Teaching Hospital Peshawar from 28th May to 27th November 2019. All patient with ACS and high neutrophil to lymphocytes ratio (NLR >4.7), of age 40–70 years old and both genders were included in the study. All those with infection/sepsis, hematological disorders, previous history of coronary artery diseases, using of immunosuppressed were excluded from the study. Result: Mean age was 55.61±6.65 years, Mean BMI was 25.25±4.32 kg/m2, Male were 130 (70.3%) and female were 55 (40.0%), Diabetes was present in 111 (60.0%) and non-diabetics were 74 (40.0%), Hypertension was present in 122 (65.9%), Smoking history was positive in 81 (43.8%). ≤45 years old were 15 (8.1%) and >45 years old were 170 (91.9%). Of BMI ≤27.00 were 126 (68.1%) while >27.00 were 59 (31.9%). The mortality rate was 14.6% (27) in hospital. Only diabetes was significant associated with mortality (p value <0.05). The gender, BMI, Hypertension, age and smoking did not show significant difference in mortality (p-value >0.05). Conclusion: There is high rate of in hospital mortality in patient with high neutrophil to lymphocytes ratio. The mortality rate further increases when the patients is diabetics. Further studies are recommended to reject or further strengthen this result. 

References

Berry JD, Dyer A, Cai X, Garside DB, Ning H, Thomas A, et al. Lifetime risks of cardiovascular disease. N Engl J Med 2012;366(4):321–9.

Jollis JG, Roettig ML, Aluko AO, Anstrom KJ, Applegate RJ, Babb JD, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. JAMA 2007;298(20):2371–80.

Bradley EH, Curry LA, Spatz ES, Herrin J, Cherlin EJ, Curtis JP, et al. Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann Intern Med 2012;156(9):618–26.

Masood A, Naveed A. Review and guidelines for the management of patients with chronic therapeutically refractory angina. Pak J Cardiol 2006;7(1):6–15.

Hasan W, Hameed S, Akbar AM, Kanwal A, Ishaq IRA, Raza A. Comparison of in-hospital outcome of patients having first acute myocardial infarction with or without pre-infarct angina. J Cardiovasc Dis 2012;10(3):79.

Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012;110(5):621–7.

Ayça B, Akın F, Celik O, Sahin I, Yildiz SS, Avci II, et al. Neutrophil to lymphocyte ratio is related to stent thrombosis and high mortality in patients with acute myocardial infarction. Angiology 2015;66(6):545–52.

Zhang S, Diao J, Qi C, Jin J, Li L, Gao X, et al. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis. BMC Cardiovasc Disord 2018;18(1):75.

Yilmaz M, Tenekecioglu E, Arslan B, Bekler A, Ozluk OA, Karaagac K, et al. White Blood Cell Subtypes and Neutrophil–Lymphocyte Ratio in Prediction of Coronary Thrombus Formation in Non-ST-Segment Elevated Acute Coronary Syndrome. Clin Appl Thromb Hemost 2015;21(5):446–52.

Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, et al. The relation between atherosclerosis and the neutrophil–lymphocyte ratio. Clin Appl Thromb Hemost 2016;22(5):405–11.

Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernández-Avilés F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 2007;28(13):1598–660.

Rafique Q, Latif M, Hussain A. To Determine the Frequency of in-Hospital Mortality in Patients of Acute Coronary Syndrome with Increased Neutrophil to Lymphocyte Ratio (NLR). 2014;8(4):946–50.

Soylu K, Gedikli Ö, Dagasan G, Aydin E, Aksan G, Nar G, et al. Neutrophil-to-lymphocyte ratio predicts coronary artery lesion complexity and mortality after non-ST-segment elevation acute coronary syndrome. Rev Port Cardiol 2015;34(7-8):465–71.

Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Circulation 2012;126(16):2020–35.

Braunwald E, Jones RH, Mark DB, Brown J, Brown L, Cheitlin MD, et al. Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. Circulation 1994;90(1):613–22.

Erturk M, Cakmak HA, Surgit O, Celik O, Aksu HU, Akgul O, et al. The predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol 2014;64(5):371–6.

Kaya MG, Akpek M, Lam YY, Yarlioglues M, Celik T, Gunebakmaz O, et al. Prognostic value of neutrophil/lymphocyte ratio in patients with ST-elevated myocardial infarction undergoing primary coronary intervention: A prospective, multicenter study. Int J Cardiol 2013;168(2):1154–9.

Published

2021-11-08